Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;140(12):2039-46.
doi: 10.1007/s00432-014-1777-1. Epub 2014 Jul 15.

Piperlongumine Induces Cell Death Through ROS-mediated CHOP Activation and Potentiates TRAIL-induced Cell Death in Breast Cancer Cells

Affiliations

Piperlongumine Induces Cell Death Through ROS-mediated CHOP Activation and Potentiates TRAIL-induced Cell Death in Breast Cancer Cells

Hyeon-Ok Jin et al. J Cancer Res Clin Oncol. .

Abstract

Purpose: Piperlongumine (PL) has been shown to selectively induce apoptotic cell death in cancer cells via reactive oxygen species (ROS) accumulation. In this study, we characterized a molecular mechanism for PL-induced cell death.

Methods: Cell viability and cell death were assessed by MTT assay and Annexin V-FITC/PI staining, respectively. ROS generation was measured using the H2DCFDA. Small interfering RNA (siRNA) was used for suppressing gene expression. The mRNA and protein expression were analyzed by RT-PCR and Western blot analysis, respectively.

Results: We found that PL promotes C/EBP homologous protein (CHOP) induction, which leads to the up-regulation of its targets Bim and DR5. Pretreatment with the ROS scavenger N-acetyl-cysteine abolishes the PL-induced up-regulation of CHOP and its target genes, suggesting an essential role for ROS in PL-induced CHOP activation. The down-regulation of CHOP or Bim with siRNA efficiently attenuates PL-induced cell death, suggesting a critical role for CHOP in this cell death. Furthermore, PL potentiates TRAIL-induced cytotoxicity in breast cancer cells by upregulating DR5, as DR5 knockdown abolished the sensitizing effect of PL on TRAIL responses.

Conclusions: Overall, our data suggest a new mechanism for the PL-induced cell death in which ROS mediates CHOP activation, and combination treatment with PL and TRAIL could be a potential strategy for breast cancer therapy.

Similar articles

See all similar articles

Cited by 10 articles

See all "Cited by" articles

References

    1. PLoS One. 2012;7(6):e39586 - PubMed
    1. Drug Resist Updat. 2004 Apr;7(2):97-110 - PubMed
    1. Genes Dev. 1994 Feb 15;8(4):453-64 - PubMed
    1. Free Radic Biol Med. 2008 Mar 15;44(6):1055-68 - PubMed
    1. Biochem Biophys Res Commun. 2013 Aug 2;437(3):463-8 - PubMed

Publication types

MeSH terms

Feedback